Premium
Interim results from a large multinational extension trial (guardian ™ 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A
Author(s) -
Lentz S. R.,
Cerqueira M.,
Janic D.,
Kempton C.,
Matytsina I.,
Misgav M.,
Oldenburg J.,
Ozelo M.,
Recht M.,
Rosholm A.,
Savic A.,
Suzuki T.,
Tiede A.,
Santagostino E.
Publication year - 2016
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12990
Subject(s) - medicine , interim , family medicine , university hospital , pediatrics , library science , law , political science , computer science